Adam Tomasz Polonek
Corporate Officer/Principal bij BIOTON S.A.
Actieve functies van Adam Tomasz Polonek
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOTON S.A. | Corporate Officer/Principal | 20-12-2011 | - |
Financieel Directeur/CFO | 01-01-2006 | 20-12-2011 | |
M.J. Group
M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Directeur/Bestuurslid | - | - |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Voorzitter | - | - |
Loopbaan van Adam Tomasz Polonek
Eerdere bekende functies van Adam Tomasz Polonek
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SCIGEN LIMITED | Directeur/Bestuurslid | 28-06-2008 | 07-08-2018 |
Financieel Directeur/CFO | 01-01-2013 | 31-08-2018 | |
Bedrijfssecretaris | 01-07-2017 | 07-08-2018 | |
Caib Financial Advisers | Corporate Officer/Principal | 01-01-2000 | 01-01-2006 |
Opleiding van Adam Tomasz Polonek
Uniwersytet Ekonomiczny w Katowicach | Undergraduate Degree |
Statistieken
Internationaal
Polen | 4 |
Singapore | 2 |
India | 2 |
Operationeel
Director/Board Member | 2 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BIOTON S.A. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
SciGen Pte Ltd.
SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
M.J. Group
M.J. Group Pharmaceuticals: MajorHealth Technology M.J. Group develops pharmaceutical products. It exports and distributes pharmaceuticals, agrochemicals, aromatic chemicals, and perfumery compounds through its subsidiaries. The company was founded by Jamal Jaffer Dewij, Abdul Jaffer Dewji and Hussein Abdulla Jaffer in 1954 and is headquartered in Mumbai, India. | Health Technology |
Biopartners GmbH
Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
Caib Financial Advisers |
- Beurs
- Insiders
- Adam Tomasz Polonek
- Ervaring